NO129771B - - Google Patents
Download PDFInfo
- Publication number
- NO129771B NO129771B NO01020/71A NO102071A NO129771B NO 129771 B NO129771 B NO 129771B NO 01020/71 A NO01020/71 A NO 01020/71A NO 102071 A NO102071 A NO 102071A NO 129771 B NO129771 B NO 129771B
- Authority
- NO
- Norway
- Prior art keywords
- water
- emulsion
- ointment
- parts
- film
- Prior art date
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 36
- 239000002674 ointment Substances 0.000 claims description 31
- 239000000839 emulsion Substances 0.000 claims description 28
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 14
- 239000011888 foil Substances 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 12
- 229940099259 vaseline Drugs 0.000 claims description 7
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 239000000758 substrate Substances 0.000 claims description 6
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 5
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 5
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 5
- 239000003995 emulsifying agent Substances 0.000 claims description 5
- 235000011187 glycerol Nutrition 0.000 claims description 5
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 4
- 150000002191 fatty alcohols Chemical class 0.000 claims description 4
- 239000003906 humectant Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000000600 sorbitol Substances 0.000 claims description 4
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 3
- 229940072056 alginate Drugs 0.000 claims description 3
- 235000010443 alginic acid Nutrition 0.000 claims description 3
- 229920000615 alginic acid Polymers 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 3
- 230000008020 evaporation Effects 0.000 claims description 3
- 239000007764 o/w emulsion Substances 0.000 claims description 3
- 239000011787 zinc oxide Substances 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- 235000019388 lanolin Nutrition 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 239000004408 titanium dioxide Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 claims 1
- 230000008961 swelling Effects 0.000 claims 1
- -1 vaseline Substances 0.000 description 7
- 239000013543 active substance Substances 0.000 description 6
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 206010052428 Wound Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 4
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 229960000458 allantoin Drugs 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 description 1
- 150000005168 4-hydroxybenzoic acids Chemical class 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- WERKSKAQRVDLDW-ANOHMWSOSA-N [(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO WERKSKAQRVDLDW-ANOHMWSOSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000999 acridine dye Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 150000001767 cationic compounds Chemical class 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 150000001887 cortisones Chemical class 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 235000010944 ethyl methyl cellulose Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000010409 ironing Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229920003087 methylethyl cellulose Polymers 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 229940053050 neomycin sulfate Drugs 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960003540 oxyquinoline Drugs 0.000 description 1
- 229940070805 p-chloro-m-cresol Drugs 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S602/00—Surgery: splint, brace, or bandage
- Y10S602/904—Film-forming bandage material
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Cosmetics (AREA)
Description
Fremgangsmåte ved fremstilling av bruksferdig Procedure for the production of ready-to-use
" salvefolie. " ointment foil.
Foreliggende oppfinnelse angår en fremgangsmåte av den art som er angitt i krav l's ingress. The present invention relates to a method of the kind stated in claim 1's preamble.
Ved dermatologisk behandling av hudoverflater såvel som ved sårbehandling har salver vært anvendt i lang tid. Salver blir i alminnelighet påfort den huddel som skal behandles eller også, In dermatological treatment of skin surfaces as well as in wound treatment, ointments have been used for a long time. Ointments are generally applied to the skin area to be treated or,
som i tilfelle ved sårbehandling, påfort en salveklut, f.eks. gas, som legges over det sted som skal behandles. For å lette behand-lingen blir gasstrimler behandlet med salve, og fremstilles for eksempel i form av salvekompresser. Slike fremgangsmåter er anvendbare kun for vannfrie salver, som vaselin, vannfri eller nesten vannfri polyethylenglycol, mens emulsjonssaIver, spesielt av typen olje-i-vann, i form av bruksferdig salvegas, er utsatt for rask ut-torkning. De idag ikke lenger vanlige salveplastere var uhåndter- as in the case of wound treatment, apply an ointment cloth, e.g. gas, which is placed over the place to be treated. To facilitate treatment, gas strips are treated with ointment, and are produced, for example, in the form of ointment compresses. Such methods are applicable only for anhydrous ointments, such as vaseline, anhydrous or almost anhydrous polyethylene glycol, while emulsion ointments, especially of the oil-in-water type, in the form of ready-to-use ointment gas, are subject to rapid drying out. The ointment plasters, which are no longer common today, were unwieldy
lige i bruk. De inneholdt hefteplastiske voks- og fettmasser som måtte oppvarmes for påforing. Anvendelse av et pudder er, selvom det er lett påforbart ved stroing, ikke i alle tilfelle hensiktsmessig, fordi den store indre overflate opptar megen fuktighet, hvilket ikke alltid er onskelig. just in use. They contained sticky plastic wax and fat masses that had to be heated for application. The use of a powder is, although it is easily applied when ironing, not always appropriate, because the large inner surface absorbs a lot of moisture, which is not always desirable.
Fremgangsmåten ifolge oppfinnelsen er særpreget ved som som er angitt i kravets karakteriserende del. Salvefolien som fremstilles ifolge fremgangsmåten består av en vannfattig emulsjon av typen olje-i-vann, og er sammensatt av: a) 20 - 60 % av en fettfase av forskjellig sammensetning, som fettalkohol, vaselin, ullfett eller lignende, The method according to the invention is characterized by what is stated in the characterizing part of the claim. The ointment foil produced according to the method consists of a water-poor emulsion of the oil-in-water type, and is composed of: a) 20 - 60% of a fat phase of different composition, such as fatty alcohol, vaseline, wool grease or the like,
b) 2 - 12 % av et emulgeringsmiddel, b) 2 - 12% of an emulsifier,
c) 3 - 20 % av en filmdanner, c) 3 - 20% of a film former,
d) IO - 40 % av et fuktighetsbevarende middel, som glycerol, sorbitol, sukker eller lignende, og e) 1 - 15 % av et terapeutisk og/eller kosmetisk aktivt middel, samt d) 10 - 40% of a humectant, such as glycerol, sorbitol, sugar or similar, and e) 1 - 15% of a therapeutic and/or cosmetically active agent, as well as
1 - 15 % vann. 1 - 15% water.
Folien kan inneholde tilsetningsmid ler som forbedrer sal-vens dekkevne, eksempelvis titandioxyd, sinkoxyd og lignende. Som emulgeringsmiddel kommer i forste rekke ikke-ioniske, anionaktive eller kationaktive forbindelser i betraktning. Filmdanneren består av methyl- eller carboxymethylcellulose, eller et annet vannopplo-selig og svellbart cellulosederivat, alginat eller lignende. The foil can contain additives that improve the covering power of the ointment, for example titanium dioxide, zinc oxide and the like. Non-ionic, anion-active or cation-active compounds are primarily considered as emulsifiers. The film former consists of methyl or carboxymethyl cellulose, or another water-soluble and swellable cellulose derivative, alginate or the like.
Salvefolien fremstilles på basis av en emulsjonssalve av typen olje-i-vann. Salven blir derved bragt i en slik form at den raskt kan anvendes, og slik at man unngår å berore det sted som skal behandles, særlig sår. Ytterligere unngår man den unodvendige omvei å bestryke en gas med salve. Derved unngåes den sterke ut-torkningstendens som oppstår ved anvendelse av pudder, og gjor anvendelse som virkestoffbærer mere universell. Det har vist seg ved anvendelse av fremgangsmåten for fremstilling av bruksferdige dannede salvefolier at alle disse krav kan fylles. The ointment foil is produced on the basis of an emulsion ointment of the oil-in-water type. The ointment is thereby brought into such a form that it can be used quickly, and so that one avoids touching the place to be treated, especially wounds. Furthermore, the unnecessary detour of coating a gas with ointment is avoided. This avoids the strong drying tendency that occurs when using powder, and makes use as an active ingredient carrier more universal. It has been shown by using the method for producing ready-to-use formed ointment foils that all these requirements can be met.
Der er gjort forsok på å konservere olje-i-vann-emulsjoner ved vannuttrekning ved hjelp av torkeforstovning henholdsvis fryse-tdrkning. Efter tilsetning av vann lar slike konsentrater seg igjen tilbakefore til olje-i-vann-emulsjon ved mekanisk bearbeidel-se, som roring. Attempts have been made to preserve oil-in-water emulsions by water extraction using dry evaporation or freeze-drying. After the addition of water, such concentrates can be returned to an oil-in-water emulsion by mechanical processing, such as stirring.
Det har overraskende vist seg at en ytterligere vannuttrekning ved hjelp av varmede flater, som en varmevalse, samtidig gir, ved egnede olje-i-vann-emulsjoner, kompakte salver i folieform som på ideell måte tilfredsstiller alle fordringer. Salvefolien kan legges direkte på den del som skal behandles, og foyer seg efter den påforte kroppsdel. Alle påforingsvanskeligheter omgåes, og anvendelsen kan gjores meget mere hygienisk enn det som er mulig ved kjent salveterapi. Dette er spesielt interessant som folge av en rask påfbring ved lesjoner på store flater, ved forbrenning og i forbindelse med kirurgiske inngrep. Salvefolier fremstillet ifolge foreliggende oppfinnelse utviser en fremragende stabilitet og kan fremstilles sterilt i hygieniske éngangsforpakninger, hvilket er en fordel som ikke utvises av kjente olje-i-vann-emulsjoner i normale tubeforpakninger. It has surprisingly been shown that a further extraction of water by means of heated surfaces, such as a heating roller, at the same time produces, with suitable oil-in-water emulsions, compact ointments in foil form which ideally satisfy all requirements. The ointment foil can be placed directly on the part to be treated, and foir itself after the applied body part. All application difficulties are avoided, and the application can be made much more hygienic than is possible with known ointment therapy. This is particularly interesting as a result of a rapid application for lesions on large surfaces, for burns and in connection with surgical interventions. Ointment foils produced in accordance with the present invention exhibit excellent stability and can be manufactured sterile in hygienic disposable packaging, which is an advantage not shown by known oil-in-water emulsions in normal tube packaging.
Utgangsmaterialene som anvendes ved den oppfinneriske The starting materials used by the inventor
fremgangsmåte er kjente olje-i-vann-emulsjoner, altså emulsjoner av-ledet av en fettfase, f.eks. mineralolje, ozokerit, vaselin, paraf-fin, fettalkoholer, planteoljer, også i hydrert form, fettsyreeste-re og lignende. Ytterligere inneholder de et emulgeringsmiddel, eksempelvis natriumcetostearylsulfat, ethoxylerte fettalkoholer eller kompleksemulgeringsmidler, som polyoxyethylenderivater av sor-bitolanhydrider, eller også såpe eller andre kationiske forbindelser. Emulsjonens vannfase inneholder et fuktighetsbevarende middel, slik som sorbitol, glycerol, sukker, polyethylenglycol eller 1,2-propylenglycol. En slik utgangsemulsjon kan inneholde kjente virkestoffer, eksempelvis desinfiserende forbindelser som p-klor-m-kresol, oxykinolin, antibiotica, sulfonamid, hexaklorofen, acridin-farvestoffer, p-hydroxybenzoesyreestere, men også desinfeksjonsmid-ler av kationisk type, som f.eks. benzalkoniumklorid, cetylpyridin-iumklorid osv. Ytterligere anvendbare virkestoffer er garvestoffer, allantoin, urea, azulen, planteekstrakter, cortisonderivater, vita-miner, hormoner osv. Hovedsakelig er alle kjente virkestoffer som kan anvendes i blje-i-vann-emulsjoner også anvendbare i salvefolier. method are known oil-in-water emulsions, i.e. emulsions derived from a fat phase, e.g. mineral oil, ozokerite, vaseline, paraffin, fatty alcohols, vegetable oils, also in hydrated form, fatty acid esters and the like. Furthermore, they contain an emulsifier, for example sodium cetostearyl sulphate, ethoxylated fatty alcohols or complex emulsifiers, such as polyoxyethylene derivatives of sorbitol anhydrides, or also soap or other cationic compounds. The water phase of the emulsion contains a humectant, such as sorbitol, glycerol, sugar, polyethylene glycol or 1,2-propylene glycol. Such a starting emulsion can contain known active substances, for example disinfectant compounds such as p-chloro-m-cresol, oxyquinoline, antibiotics, sulfonamide, hexachlorophene, acridine dyes, p-hydroxybenzoic acid esters, but also disinfectants of the cationic type, such as e.g. benzalkonium chloride, cetylpyridinium chloride, etc. Further usable active substances are tanning substances, allantoin, urea, azulene, plant extracts, cortisone derivatives, vitamins, hormones, etc. Mainly all known active substances that can be used in diaper-in-water emulsions are also usable in ointment foils .
Disse emulsjoner tilsettes én eller flere filmdannende forbindelser. Av dem som er egnede er eksempelvis carboxyvinylpo-lymerer, methylcellulose, carboxymethyleellulose og andre vannopploselige cellulosederivater, vegetabilske slimdannere, alginat, polyvinylpyrrolidon, copolymerisat av polyvinylpyrrolidon ig vinyl-acetat, agaragar, carragen eller "Dextran" osv. Emulsjonens konsistens innstilles med vann eller vann-alkoholblanding til en rela-tivt lettflytende pasta. Den erholdte pasta utstrykes ved hjelp av valsing eller bestrykning på et underlag, som metallplate, glass eller lignende, og ved oppvarmning av underlaget avdampes vannfasen til en restfuktighet på 1 - 15 %. Spesielt egnet for torkeprosessen er også varmede valser. For lettere å kunne fjerne den derved dannede film er det hensiktsmessig å belegge metallpla-ten eller valsen med et egnet kunststoff, f.eks. polyethylen eller polytetrafluorethylen, emalje eller glasur. Torketemperaturen er i området 65 - 110°C. Ved anvendelse av omfindtlige virkestoffer kan vakuum fordelaktig benyttes. Pådraget av pasta skal innstilles slik at efter torkeprosessen erholdes der en film med den onskede fi lmtykkeIse. One or more film-forming compounds are added to these emulsions. Among those that are suitable are, for example, carboxyvinyl polymers, methylcellulose, carboxymethylcellulose and other water-soluble cellulose derivatives, vegetable slime formers, alginate, polyvinylpyrrolidone, copolymer of polyvinylpyrrolidone and vinyl acetate, agar agar, carrageenan or "Dextran", etc. The consistency of the emulsion is adjusted with water or water -alcohol mixture into a relatively easy-flowing paste. The obtained paste is spread by means of rolling or coating on a substrate, such as metal plate, glass or the like, and when the substrate is heated, the water phase evaporates to a residual moisture of 1 - 15%. Heated rollers are also particularly suitable for the drying process. In order to be able to remove the resulting film more easily, it is appropriate to coat the metal plate or the roller with a suitable synthetic material, e.g. polyethylene or polytetrafluoroethylene, enamel or glaze. The drying temperature is in the range 65 - 110°C. When using bulky active substances, vacuum can be advantageously used. The application of paste must be set so that after the drying process a film with the desired film thickness is obtained.
Ved en annen utforelsesform fremstilles en emulsjon som tidligere angitt, som en tykk pasta, som derefter omdannes til en deigkonsistens i en vakuumkjele under anvendelse av varme. Deane masse utvalses til tynne folier som i henhold til den forste utforelsesform eftertdrkes på varmede plater eller valser for derved å innstille det endelige vanninnhold på det onskede nivå. In another embodiment, an emulsion is prepared as previously indicated, as a thick paste, which is then converted to a dough consistency in a vacuum boiler using heat. The resulting mass is rolled out into thin foils which, according to the first embodiment, are pressed onto heated plates or rollers to thereby set the final water content at the desired level.
Hensiktsmessig filmtykkelse er i området 0,2 - 1.5 mm. En således fremstillet kompakt salve i folieform er påforbar og flek-sibel. Når denne film påfores den hudflate som skal behandles, ligger den i nær flatekontakt med underlaget. Derved kan fuktighet uttrekkes, spesielt ved væskende eksem eller blodende sår. Angiv-else av virkestoff på overflatekontaktstedet er derved fullstendig sikret. En salvefilm fremstillet efter denne fremgangsmåte kan anvendes i sin opprinnelige form, men den kan også påvalses ensidig på et gassubstrat. Spesielt egnet er disse salvefilmer som salve-underlag ved heftplastre, eventuelt i stedet for gaspolstringen. Ved en mekanisk forbindelse mellom salvefilmene og gas kan brann-sårbandasjer fremstilles. I stedet for gas kan også andre vevnader anvendes. Salvefolien fremstillet ifolge oppfinnelsen er en vannfattig olje-i-vann-emulsjon, men som allikevel utviser en ekte emulsjons egenskaper. Den er dispergerbar i vann og danner en fly-tende emulsjon. En ytterligere inntbrkning forhindres av det an-vendte fuktighetsbevarende middel. Ytterligere kan salvefolien, inntil bruk, forsegles i et vannugjennomtrengelig materiale. Appropriate film thickness is in the range 0.2 - 1.5 mm. A thus produced compact ointment in foil form is easy to apply and flexible. When this film is applied to the skin surface to be treated, it is in close surface contact with the substrate. Thereby, moisture can be extracted, especially in the case of oozing eczema or bleeding wounds. Indication of active substance at the surface contact point is thereby completely ensured. An ointment film produced according to this method can be used in its original form, but it can also be rolled on one side on a gas substrate. These ointment films are particularly suitable as an ointment substrate for adhesive plasters, possibly instead of the gas padding. By a mechanical connection between the ointment films and gas, burn wound dressings can be produced. Instead of gas, other tissues can also be used. The ointment foil produced according to the invention is a water-poor oil-in-water emulsion, but which nevertheless exhibits the properties of a real emulsion. It is dispersible in water and forms a flowable emulsion. Further absorption is prevented by the humectant used. Furthermore, the ointment foil can be sealed in a water-impermeable material until use.
Eksempler Examples
1.) Til fremstilling av en ikke-ionisk emulsjon ble fettfasen 1.) To produce a non-ionic emulsion, the fat phase was
bestående av 3 deler vaselin, 5 deler cetostearylalkohol og 1 del fet talkoholpolyglycolether med et hydroxyltall på 80-120 consisting of 3 parts vaseline, 5 parts cetostearyl alcohol and 1 part fatty tall alcohol polyglycol ether with a hydroxyl number of 80-120
sammensmeltet. Vannfasen som besto av 2 deler lavviskos méthylcel-lulose, 1 del polyvinylpyrrolidon, 6 deler glycerol, 1 del panthe-nol, 1 del allantoin, 0,1 del benzalkoniumklorid og 80 deler vann, ble oppvarmet til ca. 70°C. Derefter ble på kjent måte vannfasen og fettfasen emulgert. Den ferdige emulsjon ble revet med 3 deler sinkoxyd. Den erholdte masse ble utstroket i en tykkelse på ca. 2 mm på en "teflon"-bestroket metallplate hvorefter vannet ble inndampet ved 100°C til en restfuktighet på ca. 3 - 4 % i filmen. Den erholdte film ble avtatt og var bruksferdig. 2. ) For fremstilling av en anionaktiv emulsjon ble fettfasen bestående av 0,2 deler paraffinolje, 3 deler ozokerit, 3 deler vaselin og 5 deler cetylstearylalkohol (DAB^) (3.tillegg), sammensmeltet. Vannfasen bestående av 2,5 deler carboxymethylcellulose, 7 deler sorbitol, 0,1 del natrium-p-klor-m-kreosolat og 90 deler vann ble oppvarmet til ca. 70°C. Vannfasen og fettfasen ble emulgert på kjent måte, og den ferdige emulsjon ble påfort en oppvarmet, langsomt roterende valse i et lag på 2 mm tykkelse, og vannet ble avdampet til en restfuktighet på ca. 5 %. 3. ) For fremstilling av en ikke-ionisk emulsjon ble en fettfa se bestående av 6 deler vaselin, 10 deler cetylstearylalkohol, 1 del stearinsyre og 2 deler polyoxyethylensorbitolmonooleat, smeltet. Vannfasen bestående av 4 deler methylcellulose, 10 deler glycerin, 1 del allantoin og 80 deler vann oppvarmet til ca. 70°C. Vannfasen og fettfasen ble emulgert på kjent måte. I den ferdige emulsjon ble 0,5 deler "Neomycinsulfat" og 0,05 deler vitamin E-acetat innarbeidet. Derefter ble emulsjonen utstroket på en plate i et 3 mm tykt lag og derefter torket i vakuum ved ca. 50°C. Restfuk-tigheten i den erholdte film var 5 %. 4. ) En anionaktiv emulsjon ble fremstillet av en vannfase be stående av 3,3 deler vaselin, 6,4 deler emulgerende cetylstearylalkohol (DAB^(3.tillegg)), 0,5 deler polyethylenglycol-400-stearat, 0,1 del p-hydroxybenzoesyrebutylester, 0,2 deler "Adeps lanae" som ble sammensmeltet. Vannfasen bestående av 2,2 deler carboxymethylcellulose, 1,2 deler polyvinylpyrrolidon, 5 deler "Polyethylenglycol 4O0", 3 deler urea og 60 deler vann ble oppvarmet til ca. 70°C. Vannfasen og fettfasen ble emulgert på kjent måte, hvorefter den erholdte masse ble inndampet i en vakuumkjele under om-roring inntil en deigaktig konsistens ble erholdt. Denne pastalig-nende masse ble utvalset tynt på en metallplate og derefter torket ved 100°C inntil en restfuktighet på ca. 5 %. 5.) Emulsjonen ifolge eksempel 1 ble utstroket på en metall plate i et ca. 3 mm tykt lag. For fordelingen på metall-platen blir et lag gas innlemret i massen. Derefter fjernes vannet ved avdampning ved ca. 100°C til en restfuktighet på ca. 3 - 4 %. merged. The water phase, which consisted of 2 parts low-viscosity methyl cellulose, 1 part polyvinylpyrrolidone, 6 parts glycerol, 1 part panthenol, 1 part allantoin, 0.1 part benzalkonium chloride and 80 parts water, was heated to approx. 70°C. The water phase and the fat phase were then emulsified in a known manner. The finished emulsion was torn with 3 parts zinc oxide. The mass obtained was spread out to a thickness of approx. 2 mm on a Teflon-coated metal plate, after which the water was evaporated at 100°C to a residual moisture of approx. 3 - 4% in the film. The obtained film was taken down and was ready for use. 2. ) For the production of an anionic emulsion, the fat phase was consisting of 0.2 parts of paraffin oil, 3 parts of ozokerite, 3 parts of vaseline and 5 parts of cetyl stearyl alcohol (DAB^) (3rd addition), fused. The water phase consisting of 2.5 parts carboxymethylcellulose, 7 parts sorbitol, 0.1 part sodium p-chloro-m-creosolate and 90 parts water was heated to approx. 70°C. The water phase and the fat phase were emulsified in a known manner, and the finished emulsion was applied to a heated, slowly rotating roller in a layer of 2 mm thickness, and the water was evaporated to a residual moisture of approx. 5%. 3. ) For the preparation of a non-ionic emulsion, a fat fa see consisting of 6 parts vaseline, 10 parts cetyl stearyl alcohol, 1 part stearic acid and 2 parts polyoxyethylene sorbitol monooleate, melted. The water phase consisting of 4 parts methylcellulose, 10 parts glycerin, 1 part allantoin and 80 parts water heated to approx. 70°C. The water phase and the fat phase were emulsified in a known manner. In the finished emulsion, 0.5 parts of "Neomycin sulfate" and 0.05 parts of vitamin E acetate were incorporated. The emulsion was then spread on a plate in a 3 mm thick layer and then dried in vacuum at approx. 50°C. The residual moisture in the obtained film was 5%. 4. ) An anionic emulsion was prepared from a water phase be consisting of 3.3 parts petroleum jelly, 6.4 parts emulsifying cetyl stearyl alcohol (DAB^(3rd addition)), 0.5 parts polyethylene glycol-400 stearate, 0.1 part p-hydroxybenzoic acid butyl ester, 0.2 parts "Adeps lanae" which were merged. The water phase consisting of 2.2 parts carboxymethylcellulose, 1.2 parts polyvinylpyrrolidone, 5 parts "Polyethyleneglycol 4O0", 3 parts urea and 60 parts water was heated to approx. 70°C. The water phase and the fat phase were emulsified in a known manner, after which the obtained mass was evaporated in a vacuum boiler with stirring until a pasty consistency was obtained. This paste-like mass was rolled out thinly on a metal plate and then dried at 100°C until a residual moisture of approx. 5%. 5.) The emulsion according to example 1 was spread on a metal plate in an approx. 3 mm thick layer. For distribution on the metal plate, a layer of gas is incorporated into the mass. The water is then removed by evaporation at approx. 100°C to a residual moisture of approx. 3 - 4%.
Claims (5)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2012775A DE2012775C3 (en) | 1970-03-18 | 1970-03-18 | Ointment foils and process for their manufacture |
Publications (1)
Publication Number | Publication Date |
---|---|
NO129771B true NO129771B (en) | 1974-05-27 |
Family
ID=5765402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO01020/71A NO129771B (en) | 1970-03-18 | 1971-03-17 |
Country Status (15)
Country | Link |
---|---|
US (1) | US3803300A (en) |
AT (1) | AT302530B (en) |
BE (1) | BE764422A (en) |
CA (1) | CA945897A (en) |
CH (1) | CH575758A5 (en) |
DE (1) | DE2012775C3 (en) |
DK (1) | DK131088B (en) |
ES (1) | ES388980A1 (en) |
FR (1) | FR2083366B1 (en) |
GB (1) | GB1320309A (en) |
IE (1) | IE35025B1 (en) |
LU (1) | LU62798A1 (en) |
NL (1) | NL7103560A (en) |
NO (1) | NO129771B (en) |
SE (1) | SE368508B (en) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2432925C3 (en) * | 1974-07-05 | 1985-11-21 | Schering AG, 1000 Berlin und 4709 Bergkamen | Film-shaped medicinal products |
AR207805A1 (en) * | 1975-02-06 | 1976-10-29 | Alza Corp | SUITABLE SUBSTRATE TO FORM DRESSINGS FOR THE CONTINUOUS DISPENSATION OF BASE SCCOPOLAMINE BY TRANSDERMAL ROUTE |
DE2517452C3 (en) * | 1975-04-19 | 1978-11-02 | Fa. Carl Freudenberg, 6940 Weinheim | Collagen foil for cosmetic use |
US4113854A (en) * | 1977-01-10 | 1978-09-12 | Minnesota Mining And Manufacturing Company | Prophylactic treatment of mastitis |
FR2405068A1 (en) * | 1977-10-10 | 1979-05-04 | Sauba Lab | Water in oil emulsions for dry skin - contg. vitamin=A, stigmasterol, allantoin, and alpha tocopherol |
US4291014A (en) * | 1979-01-11 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing estradiol diacetate |
FR2455459A1 (en) * | 1979-05-02 | 1980-11-28 | Sertog | Carboxy:methylcellulose matrix for slow release of volatile cpd. - contains tri:ethanolamine, stearin and an alcohol e.g. cetyl is esp. useful for perfumes, insect repellents eczema treatment etc. |
US4291015A (en) * | 1979-08-14 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing a vasodilator |
CA1163559A (en) * | 1980-07-09 | 1984-03-13 | Alec D. Keith | Polymeric diffusion matrix for administration of drugs |
US4357935A (en) * | 1980-11-12 | 1982-11-09 | C. R. Canfield & Company, Inc. | Dry method of making a dry socket dressing |
IL61721A (en) * | 1980-12-16 | 1984-03-30 | Blank Izhak | Nitroglycerin preparations |
US4591501A (en) * | 1981-04-13 | 1986-05-27 | Seton Company | Cosmetic and pharmaceutical sheet material containing polypeptides |
US4585797A (en) * | 1981-04-13 | 1986-04-29 | Seton Company | Cosmetic and pharmaceutical sheet material containing polypeptides |
US4482533A (en) * | 1982-01-11 | 1984-11-13 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing propranolol |
EP0139127A1 (en) * | 1983-08-22 | 1985-05-02 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Transdermal drug delivery device and its preparation |
FR2649318A1 (en) * | 1989-07-07 | 1991-01-11 | Tisnes Paul | Dehydrated pharmaceutical dosage forms for dermatological and cosmetic use |
EP0409383B1 (en) * | 1989-07-21 | 1994-04-06 | Izhak Blank | Estradiol compositions and methods for topical applications |
US5232703A (en) * | 1989-07-21 | 1993-08-03 | Izhak Blank | Estradiol compositions and methods for topical application |
GB9017800D0 (en) * | 1990-08-14 | 1990-09-26 | Unilever Plc | Moisture barrier and its preparation |
US6221403B1 (en) * | 1992-08-08 | 2001-04-24 | Seton Healthcare Group Plc | Topical composition |
GB2269745B (en) * | 1992-08-08 | 1996-08-07 | Seton Healthcare Group Plc | A zinc oxide topical composition |
DE4420625C1 (en) * | 1994-06-14 | 1995-11-02 | Beiersdorf Ag | Active substance combination with a content of glycerylalkyl ethers and cosmetic and dermatological preparations containing such active substance combinations |
US20030211136A1 (en) * | 1998-09-25 | 2003-11-13 | Neema Kulkarni | Fast dissolving orally consumable films containing a sweetener |
US6596298B2 (en) | 1998-09-25 | 2003-07-22 | Warner-Lambert Company | Fast dissolving orally comsumable films |
US20030206942A1 (en) * | 1998-09-25 | 2003-11-06 | Neema Kulkarni | Fast dissolving orally consumable films containing an antitussive and a mucosa coating agent |
US6245960B1 (en) | 1999-05-13 | 2001-06-12 | Board Of Trustees Of The University Of Arkansas | Inherent healing accelerator |
DE10034491A1 (en) * | 2000-07-15 | 2002-01-24 | Scs Skin Care Systems Gmbh | Foil dermatics |
US20040228892A1 (en) * | 2003-02-28 | 2004-11-18 | Berry Craig J. | Delivery system for cosmetic and skincare products |
US7666396B2 (en) * | 2003-09-11 | 2010-02-23 | Kimberly-Clark Worldwide, Inc. | Single-use moisturizing product |
US20070110792A9 (en) * | 2005-01-03 | 2007-05-17 | L'oreal | Cosmetic or dermatological article comprising a medium that is soluble in water |
FR2880262B1 (en) * | 2005-01-03 | 2013-11-08 | Oreal | COSMETIC OR DERMATOLOGICAL ARTICLE COMPRISING A WATER-SOLUBLE SUPPORT |
US20070259029A1 (en) * | 2006-05-08 | 2007-11-08 | Mcentire Edward Enns | Water-dispersible patch containing an active agent for dermal delivery |
US20070258935A1 (en) * | 2006-05-08 | 2007-11-08 | Mcentire Edward Enns | Water dispersible films for delivery of active agents to the epidermis |
US20080057090A1 (en) * | 2006-09-01 | 2008-03-06 | Mcentire Edward Enns | Wrinkle masking film composition for skin |
US7879942B2 (en) * | 2006-10-05 | 2011-02-01 | Eastman Chemical Company | Switchable adhesive article for attachment to skin and method of using the same |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR851701A (en) * | 1938-03-15 | 1940-01-13 | Protective paste |
-
1970
- 1970-03-18 DE DE2012775A patent/DE2012775C3/en not_active Expired
-
1971
- 1971-03-05 US US00121555A patent/US3803300A/en not_active Expired - Lifetime
- 1971-03-06 ES ES388980A patent/ES388980A1/en not_active Expired
- 1971-03-10 CH CH361871A patent/CH575758A5/xx not_active IP Right Cessation
- 1971-03-11 DK DK114671AA patent/DK131088B/en unknown
- 1971-03-12 FR FR7108699A patent/FR2083366B1/fr not_active Expired
- 1971-03-16 LU LU62798D patent/LU62798A1/xx unknown
- 1971-03-17 NO NO01020/71A patent/NO129771B/no unknown
- 1971-03-17 AT AT228571A patent/AT302530B/en not_active IP Right Cessation
- 1971-03-17 CA CA108,015A patent/CA945897A/en not_active Expired
- 1971-03-17 NL NL7103560A patent/NL7103560A/xx unknown
- 1971-03-17 BE BE764422A patent/BE764422A/en unknown
- 1971-03-17 SE SE03438/71A patent/SE368508B/xx unknown
- 1971-03-18 IE IE346/71A patent/IE35025B1/en unknown
- 1971-04-19 GB GB2449571*A patent/GB1320309A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
ES388980A1 (en) | 1974-05-01 |
FR2083366A1 (en) | 1971-12-17 |
DE2012775B2 (en) | 1973-03-01 |
DE2012775C3 (en) | 1973-10-04 |
US3803300A (en) | 1974-04-09 |
DK131088B (en) | 1975-05-26 |
LU62798A1 (en) | 1971-08-23 |
IE35025L (en) | 1971-09-18 |
DK131088C (en) | 1975-10-27 |
GB1320309A (en) | 1973-06-13 |
DE2012775A1 (en) | 1971-09-30 |
NL7103560A (en) | 1971-09-21 |
CH575758A5 (en) | 1976-05-31 |
AT302530B (en) | 1972-10-25 |
CA945897A (en) | 1974-04-23 |
BE764422A (en) | 1971-08-16 |
SE368508B (en) | 1974-07-08 |
FR2083366B1 (en) | 1974-05-31 |
IE35025B1 (en) | 1975-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO129771B (en) | ||
AU2001283909B2 (en) | Solution-, Dispersion-or emulsion-producing film dermatics | |
DE2432925B2 (en) | Film-shaped drugs or placebos | |
CA1067407A (en) | Pharmaceutical preparation in the form of a foil having an active substance incorporated therein | |
US5456745A (en) | Flexible, hydrophilic gel film, the process for its production and the use of it | |
US20040143026A1 (en) | Bioadhesive hydrophilic composition for treatment of mammalian skin | |
HUT75288A (en) | Hydrophilic, hot-melt-type pressure-sensitive adhesive | |
JPH05504895A (en) | transdermal system | |
NO180618B (en) | Process for the preparation of compositions which form in situ films on body tissue | |
DE2449865B2 (en) | Film-shaped medicinal product | |
MXPA06003316A (en) | Transdermal pharmaceutical formulation for minimizing skin residues. | |
US20100126650A1 (en) | Process for producing preparation for oral administration | |
US2464755A (en) | Coated gauze | |
NO124623B (en) | ||
EP1711160A2 (en) | Flat system for using in the oral cavity | |
NL8302492A (en) | CROSSES POLY BETA-ALANINE AND ITS DIFFERENT APPLICATIONS. | |
JPH05194180A (en) | Sheet-formed pack cosmetic | |
DE19712699C2 (en) | Process for the production of wound dressings with wound care active substances | |
RU2295956C2 (en) | Potentiated compositions for topical using | |
TWI776879B (en) | body makeup | |
Kishchenko et al. | Films in Russian medicine and cosmetology: development history, classification, technology | |
WO2021002124A1 (en) | Moisturizing film cosmetic material | |
Vakhariya et al. | Preparation of novel biocompatible honey hydrogel with turmaric and Aloe vera. | |
JPH0436133B2 (en) | ||
Tarasenko et al. | Features of the development of soft dosage forms |